Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313429906> ?p ?o ?g. }
- W4313429906 endingPage "1091" @default.
- W4313429906 startingPage "1085" @default.
- W4313429906 abstract "Background Asthma guidelines have recommended continuing treatment with biologics during coronavirus disease 2019 (COVID-19) pandemic. However, a continuation of treatment with biologics in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been little investigated. Objective To assess the safety of biologics in patients with SARS-CoV-2 infection. Methods A pilot, monocentric, prospective study. Patients aged 6 years old and older with severe asthma on treatment with biologics and confirmed SARS-CoV-2 infection were enrolled. Patients were followed-up with periodic calls at different time points up to 3 months to detect any adverse effect and its relationship with biologic treatment according to the Naranjo Adverse Probability Scale (NAPS). The severity of SARS-CoV-2 infection and clinical outcome were also assessed. Results Overall, we included 21 patients (10 on therapy with omalizumab, 9 with dupilumab, and 2 with mepolizumab). Only a patient-reported two local adverse events. No other adverse event was reported. Twenty out of 21 patients had a mild COVID-19 course, and no adverse outcome was observed. Conclusion We showed that the scheduled dose of the biologic therapy can be administered safely on time in patients with SARS-CoV-2 infection, as the treatment did not result in adverse events or outcomes." @default.
- W4313429906 created "2023-01-06" @default.
- W4313429906 creator A5004932142 @default.
- W4313429906 creator A5010175243 @default.
- W4313429906 creator A5038437222 @default.
- W4313429906 creator A5047301148 @default.
- W4313429906 creator A5050972227 @default.
- W4313429906 creator A5056614175 @default.
- W4313429906 creator A5058891335 @default.
- W4313429906 creator A5067545038 @default.
- W4313429906 creator A5091783415 @default.
- W4313429906 date "2023-01-13" @default.
- W4313429906 modified "2023-10-18" @default.
- W4313429906 title "Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study" @default.
- W4313429906 cites W2067978628 @default.
- W4313429906 cites W2137404654 @default.
- W4313429906 cites W2138355864 @default.
- W4313429906 cites W2267403317 @default.
- W4313429906 cites W2751934223 @default.
- W4313429906 cites W2803941918 @default.
- W4313429906 cites W2805242271 @default.
- W4313429906 cites W2944522746 @default.
- W4313429906 cites W3019170675 @default.
- W4313429906 cites W3025842080 @default.
- W4313429906 cites W3033402428 @default.
- W4313429906 cites W3035324200 @default.
- W4313429906 cites W3092371459 @default.
- W4313429906 cites W3096610536 @default.
- W4313429906 cites W3116399178 @default.
- W4313429906 cites W3118794470 @default.
- W4313429906 cites W3121848516 @default.
- W4313429906 cites W3126994626 @default.
- W4313429906 cites W3135413123 @default.
- W4313429906 cites W3156262466 @default.
- W4313429906 cites W3207588227 @default.
- W4313429906 cites W3210198427 @default.
- W4313429906 cites W4206085189 @default.
- W4313429906 cites W4225009223 @default.
- W4313429906 cites W4288074876 @default.
- W4313429906 cites W4288096714 @default.
- W4313429906 cites W4312376273 @default.
- W4313429906 doi "https://doi.org/10.1002/ppul.26298" @default.
- W4313429906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36593591" @default.
- W4313429906 hasPublicationYear "2023" @default.
- W4313429906 type Work @default.
- W4313429906 citedByCount "1" @default.
- W4313429906 countsByYear W43134299062023 @default.
- W4313429906 crossrefType "journal-article" @default.
- W4313429906 hasAuthorship W4313429906A5004932142 @default.
- W4313429906 hasAuthorship W4313429906A5010175243 @default.
- W4313429906 hasAuthorship W4313429906A5038437222 @default.
- W4313429906 hasAuthorship W4313429906A5047301148 @default.
- W4313429906 hasAuthorship W4313429906A5050972227 @default.
- W4313429906 hasAuthorship W4313429906A5056614175 @default.
- W4313429906 hasAuthorship W4313429906A5058891335 @default.
- W4313429906 hasAuthorship W4313429906A5067545038 @default.
- W4313429906 hasAuthorship W4313429906A5091783415 @default.
- W4313429906 hasConcept C126322002 @default.
- W4313429906 hasConcept C141105273 @default.
- W4313429906 hasConcept C159654299 @default.
- W4313429906 hasConcept C177713679 @default.
- W4313429906 hasConcept C187212893 @default.
- W4313429906 hasConcept C188816634 @default.
- W4313429906 hasConcept C197934379 @default.
- W4313429906 hasConcept C203014093 @default.
- W4313429906 hasConcept C2776042228 @default.
- W4313429906 hasConcept C2777037409 @default.
- W4313429906 hasConcept C2777832160 @default.
- W4313429906 hasConcept C2778564945 @default.
- W4313429906 hasConcept C2779134260 @default.
- W4313429906 hasConcept C30036603 @default.
- W4313429906 hasConcept C3007834351 @default.
- W4313429906 hasConcept C3008058167 @default.
- W4313429906 hasConcept C524204448 @default.
- W4313429906 hasConcept C71924100 @default.
- W4313429906 hasConcept C89623803 @default.
- W4313429906 hasConceptScore W4313429906C126322002 @default.
- W4313429906 hasConceptScore W4313429906C141105273 @default.
- W4313429906 hasConceptScore W4313429906C159654299 @default.
- W4313429906 hasConceptScore W4313429906C177713679 @default.
- W4313429906 hasConceptScore W4313429906C187212893 @default.
- W4313429906 hasConceptScore W4313429906C188816634 @default.
- W4313429906 hasConceptScore W4313429906C197934379 @default.
- W4313429906 hasConceptScore W4313429906C203014093 @default.
- W4313429906 hasConceptScore W4313429906C2776042228 @default.
- W4313429906 hasConceptScore W4313429906C2777037409 @default.
- W4313429906 hasConceptScore W4313429906C2777832160 @default.
- W4313429906 hasConceptScore W4313429906C2778564945 @default.
- W4313429906 hasConceptScore W4313429906C2779134260 @default.
- W4313429906 hasConceptScore W4313429906C30036603 @default.
- W4313429906 hasConceptScore W4313429906C3007834351 @default.
- W4313429906 hasConceptScore W4313429906C3008058167 @default.
- W4313429906 hasConceptScore W4313429906C524204448 @default.
- W4313429906 hasConceptScore W4313429906C71924100 @default.
- W4313429906 hasConceptScore W4313429906C89623803 @default.
- W4313429906 hasIssue "4" @default.
- W4313429906 hasLocation W43134299061 @default.
- W4313429906 hasLocation W43134299062 @default.